Updated

Researchers identified an experimental compound, AP503, that activates the receptor GPR133 to boost bone formation while slowing bone loss, significantly strengthening bones in mouse studies. The same pathway has also been linked to stronger muscles, raising interest in its potential to combat age-related decline and osteoporosis in humans.